Source: Virtual Congress 2021 – Precision medicine in asthma and COPD



Rating:

Share or cite this content

Citations should be made in the following way:
C. Brightling (Leicester (Leicestershire), United Kingdom). Linking phenotypes to personalised treatments in asthma and COPD. Virtual Congress 2021 – Precision medicine in asthma and COPD

Member's Comments

No comment yet.

Related content which might interest you: Targeting traits in asthma and COPD Source: Virtual Congress 2021 – Pharmacology of lung immune responses: which pathways to target! Year: 2021 Pharmacological strategies for self-management of asthma exacerbations Source: Eur Respir J 2006; 28: 182-199 Year: 2006 Defining asthma phenotypes Source: Annual Congress 2013 –MS4 Asthma phenotypes and endotypes Year: 2013 Identifying asthma features in severe COPD Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Targeting the epigenome in asthma and COPD Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013 Is there a need for pharmacoepidemiology in asthma and COPD? Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials Year: 2004 Complex and multifaceted physiology of asthma and COPD Source: Virtual Congress 2021 – Precision medicine in asthma and COPD Year: 2021 Mechanisms in COPD compared with asthma Source: Breathe 2008; 5: 134-144 Year: 2008 Role of biomarkers in the assessment and phenotyping asthma and COPD Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases Year: 2017 Efficiency of different approaches for the assessment of the risk of exacerbations in patients with COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Refining asthma treatment for mild asthma Source: Virtual Congress 2020 – Rethinking asthma Year: 2020 Assessment of a disease management program for patients with asthma or COPD Source: Eur Respir J 2005; 26: Suppl. 49, 19s Year: 2005 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 From guidelines to personalized treatment of children with asthma Source: Virtual Congress 2020 – Which paediatric asthma guidelines are the most appropriate for children and adolescents? Year: 2020